Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ether SCHEMBL4417828 | 1.00 | ALDH1A1 (0.47) | ALDH1A1TSHRHTTLMNAPOLB | |
| Ether SCHEMBL1559716 | 1.00 | ALDH1A1 (0.47) | ALDH1A1TSHRHTTLMNAPOLB | |
| Tetrahydrofuran SCHEMBL2114570 | 0.97 | ALDH1A1 (0.50) | ALDH1A1TSHRHTTLMNAPOLB | |
| Tetrahydrofuran SCHEMBL3966212 | 0.97 | ALDH1A1 (0.50) | ALDH1A1TSHRHTTLMNAPOLB | |
| Tetrahydrofuran SCHEMBL139042 | 0.97 | ALDH1A1 (0.50) | ALDH1A1TSHRHTTLMNAPOLB | |
| Dioxane SCHEMBL8034299 | 0.94 | ALDH1A1 (0.47) | ALDH1A1TSHRHTTLMNAPOLB | |
| Tetrahydrofuran SCHEMBL28266595 | 0.94 | ALDH1A1 (0.47) | ALDH1A1TSHRHTTLMNAPOLB | |
| Tetrahydrofuran SCHEMBL28163248 | 0.94 | ALDH1A1 (0.47) | ALDH1A1TSHRHTTLMNAPOLB | |
| Tetrahydrofuran SCHEMBL8982353 | 0.94 | ALDH1A1 (0.47) | ALDH1A1TSHRHTTLMNAPOLB | |
| Tetrahydrofuran SCHEMBL10676279 | 0.94 | ALDH1A1 (0.47) | ALDH1A1TSHRHTTLMNAPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 242 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111662318-B | Iloprost key intermediate and preparation method thereof | 上海医药工业研究院 | 2024-02-02 | — | — | CN | claimed |
| CN-111662318-A | Iloprost key intermediate and preparation method thereof | 上海医药工业研究院 | 2020-09-15 | — | — | CN | claimed |
| CN-101759601-B | Method for preparing chiral alpha-unnatural amino acid by transition metal complex | OKEANOS TECH CO LTD | 2013-07-24 | — | — | CN | claimed |
| CN-102617343-A | Adsorption chromatography purification method for 8-acetoxy caprylic aldehyde | SHIJIAZHUANG VIAO CHEMICAL CO LTD | 2012-08-01 | — | — | CN | claimed |
| US-8124789-B2 | Method for producing glycosylated indole compound and antibody against the compound | RIKEN (JP) | 2012-02-28 | — | — | US | claimed |
| CN-101759601-A | Method for preparing chiral alpha-unnatural amino acid by transition metal complex | OKEANOS TECH CO LTD | 2010-06-30 | — | — | CN | claimed |
| US-20100028329-A1 | METHOD FOR PRODUCING GLYCOSYLATED INDOLE COMPOUND AND ANTIBODY AGAINST THE COMPOUND | RIKEN (JP) | 2010-02-04 | — | — | US | claimed |
| WO-2005058246-A2 | METHOD FOR PREPARING RADIOLABELED THYMIDINE | MOLECULAR TECHNOLOGIES, INC. (US) | 2005-06-30 | — | — | WO | claimed |
| US-20050131224-A1 | Method for preparing radiolabeled thymidine | CTI PET SYSTEMS, INC. | 2005-06-16 | — | — | US | claimed |
| EP-0520265-B1 | Positive working radiation-sensitive composition with disulfone acid generators | BASF AG (DE) | 1999-11-17 | — | — | EP | claimed |
| CN-112351781-B | Imidazodiazepine diketones and methods of use thereof | 金翅雀生物公司 | 2024-07-02 | — | — | CN | disclosed |
| CN-118215506-A | Anthracycline derivative linker reagent, antibody-drug conjugate and method | 内尔维亚诺医疗科学公司 | 2024-06-18 | — | — | CN | disclosed |
| CN-118108576-A | Method for removing tetrahydropyran protecting groups on alcohols and phenols | 南京工业大学 | 2024-05-31 | — | — | CN | disclosed |
| CN-118059093-A | Inhibitors of short chain dehydrogenase activity for the treatment of fibrosis | 卡斯西部储备大学 | 2024-05-24 | — | — | CN | disclosed |
| CN-110799190-B | Heterocyclic compounds | 卡都瑞恩医药有限公司 | 2024-04-19 | — | — | CN | disclosed |
| EP-0038160-A1 | Quinone compounds, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1981-10-21 | — | — | EP | disclosed |
| US-4197286-A | ANTI-TESTOSTERONE SERUM FOR USE OF RADIOIMMUNOASSAY METHODS TO MEASURE TESTOSTERONE | SOUTHWEST RESEARCH INSTITUTE (US) | 1980-04-08 | — | — | US | disclosed |
| US-4144251-A | PROSTAGLANDINS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1979-03-13 | — | — | US | disclosed |
| US-4048328-A | HYPERTENSIVE AGENTS, BRONCHODILATOR AGENTS, GASTROINTESTINAL DISORDERS, PROSTAGLANDINS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1977-09-13 | — | — | US | disclosed |
| US-3983154-A | Racemic prostaglandins of the 2-series and analogs thereof | THE UPJOHN COMPANY (US) | 1976-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050131224-A1 | Method for preparing radiolabeled thymidine | TYMP, TYMS, DUT | ALDH1A1 2386/4885TSHR 583/4885HTT 2422/4885 |
| US-20100028329-A1 | METHOD FOR PRODUCING GLYCOSYLATED INDOLE COMPOUND AND ANTIBODY AGAINST THE COMPOUND | TPH1, IDO1, TPH2 | ALDH1A1 803/4885TSHR 310/4885HTT 2018/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.